Just gotta stay positive. If no issues with SB, then share price should be ATH. Makes me wonder how many are still holding after the acne debacle.
I think Grainofsand could be right in that even with FDA approval of SB, strong share price appreciation may still take sometime as institutional investors would want to see the revenue from sales.
I think we’ve gotta temper our shorter term share price expectations with this company a little bit. Mid-cycle review definitely showed that. Had no idea we’d be well under 10cents post mid-cycle.
BOT is a puzzling share to hold sometimes…
BOT - Anything but charting, page-4493
-
- There are more pages in this discussion • 4,780 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
38.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $687.8M | |||
| Open | High | Low | Value | Volume |
| 37.5¢ | 38.0¢ | 35.0¢ | $4.519M | 12.27M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 75362 | 37.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 38.0¢ | 326113 | 17 |
View Market Depth
| Last trade - 16.10pm 15/07/2024 (20 minute delay) ? |
| BOT (ASX) Chart |